title: Changes of in vitro potency of anticoagulant drugs are similar between patients with cirrhosis due to alcohol or non-alcoholic fatty liver disease.
authors.affiliation: Department of Internal Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; Surgical Research Laboratory, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
authors.forename: Sarah
authors.initials: S
authors.lastname: Bos
authors.affiliation: Surgical Research Laboratory, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
authors.forename: Wilma
authors.initials: W
authors.lastname: Potze
authors.affiliation: Division of Gastroenterology, Hepatology and Nutrition, Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmond, VA 23298., United States.
authors.forename: Mohammad S
authors.initials: MS
authors.lastname: Siddiqui
authors.affiliation: Division of Gastroenterology, Hepatology and Nutrition, Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmond, VA 23298., United States.
authors.forename: Sherry L
authors.initials: SL
authors.lastname: Boyett
authors.affiliation: Surgical Research Laboratory, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
authors.forename: Jelle
authors.initials: J
authors.lastname: Adelmeijer
authors.affiliation: Division of Gastroenterology, Hepatology and Nutrition, Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmond, VA 23298., United States.
authors.forename: Kalyani
authors.initials: K
authors.lastname: Daita
authors.affiliation: Surgical Research Laboratory, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; Section of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. Electronic address: j.a.lisman@umcg.nl.
authors.forename: Ton
authors.initials: T
authors.lastname: Lisman
authors.affiliation: Division of Gastroenterology, Hepatology and Nutrition, Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmond, VA 23298., United States.
authors.forename: Arun J
authors.initials: AJ
authors.lastname: Sanyal
mesh_terms: D000328:Adult; D000437:Alcoholism / Q000097:blood / Q000150:complications*; D000925:Anticoagulants / Q000494:pharmacology* / Q000627:therapeutic use; D000069604:Dabigatran / Q000494:pharmacology / Q000627:therapeutic use; D017984:Enoxaparin / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D006487:Hemostasis / Q000187:drug effects*; D006801:Humans; D008103:Liver Cirrhosis / Q000097:blood / Q000150:complications / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D065626:Non-alcoholic Fatty Liver Disease / Q000097:blood / Q000150:complications*; D011720:Pyrazoles / Q000494:pharmacology / Q000627:therapeutic use; D011728:Pyridones / Q000494:pharmacology / Q000627:therapeutic use; D013927:Thrombosis / Q000209:etiology / Q000517:prevention & control
chemical_list: D000925:Anticoagulants; D017984:Enoxaparin; D011720:Pyrazoles; D011728:Pyridones; C522181:apixaban; D000069604:Dabigatran